NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/22/2025
Back to search
Official data from USPTO
BD ONCLARITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/23/2025
Trademark type
Combined
Nice classes
5
Filing date
11/28/2016
Registration date
01/08/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/22/2025
Last transaction
05/23/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/11/2018
First use in commerce
05/11/2018
Drawing code
3
Owner type
03
Owner location
Franklin Lakes, NJ
Examiner
BODRI, KRISTIN
Current location
Historical data usage
Mark description
The mark consists of a shaded circle containing a sunburst design and a partial arc design; next to the shaded circle are the letters "BD" and the word "OnClarity".
Holders and representatives
Holders
Becton, Dickinson and Company
Representatives
Ken M. Sheets Whitestone Law PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
in vitro diagnostic reagents for medical use and assay kits for medical use comprising medical diagnostic reagents and assays for the detection of diseasescancer and HPV
Publications
History of USPTO decisions and trademark events.
41 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/22/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/22/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/30/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/08/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/05/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/03/2018
ALIE
ASSIGNED TO LIE
11/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/26/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/26/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/01/2018
GNRT
NON-FINAL ACTION E-MAILED
10/01/2018
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/10/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/10/2018
IUAF
USE AMENDMENT FILED
08/15/2018
EISU
TEAS STATEMENT OF USE RECEIVED
08/15/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/24/2018
EX1G
SOU EXTENSION 1 GRANTED
01/22/2018
EXT1
SOU EXTENSION 1 FILED
01/22/2018
EEXT
SOU TEAS EXTENSION RECEIVED
01/22/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/15/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/20/2017
PUBO
PUBLISHED FOR OPPOSITION
06/20/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/31/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/11/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/03/2017
GNRT
NON-FINAL ACTION E-MAILED
03/03/2017
CNRT
NON-FINAL ACTION WRITTEN
03/03/2017
DOCK
ASSIGNED TO EXAMINER
03/02/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2016
NWAP
NEW APPLICATION ENTERED
12/01/2016
Continuous trademark protection
Get notified about every new filing that threatens BD ONCLARITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.